Powered by
Pulse Biosciences to Host Investor Conference Call on March 14, 2017

Pulse Biosciences, Inc., (Nasdaq: PLSE) a medical technology company developing a proprietary therapeutic tissue treatment platform based on Nano-Pulse Stimulation (NPS), will host its first quarter investor conference call on March 14, 2017, at 1:30 p.m. PDT / 4:30 p.m. EDT. The company will highlight progress to-date on its NPS clinical programs, PulseTx System development, as well as provide an update on recent financial results and developments including financial results for the quarter and

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox